Emverm
NDC Package 52054-107-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Emverm is mebendazole is used to treat intestinal worm infections such as pinworm, roundworm, and hookworm. Marketed by Amedra Pharmaceuticals Llc, this product is identified by NDC 52054-107 and is authorized under FDA application ANDA073580.

Identification & Billing

NDC Package Code
52054-107-01
Package Description
1 BLISTER PACK in 1 CARTON / 1 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
52054010701
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Emverm
Dosage Form
-
Usage Information
Mebendazole is used to treat intestinal worm infections such as pinworm, roundworm, and hookworm.

Regulatory & Marketing

Labeler Name
Amedra Pharmaceuticals Llc
FDA Application #
ANDA073580
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-15-2016
End Marketing Date
11-30-2018
Listing Expiration
11-30-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52054-107-01 identifies a specific commercial package of 1 blister pack in 1 carton / 1 tablet, chewable in 1 blister pack of Emverm, labeled by Amedra Pharmaceuticals Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Amedra Pharmaceuticals Llc on February 15, 2016. The current certification is valid through November 30, 2018.

What are the primary indications for this medication?

Mebendazole is used to treat intestinal worm infections such as pinworm, roundworm, and hookworm.

How is this Amedra Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52054010701. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52054-107-01
11-Digit CMS (5-4-2)
52054-0107-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.